How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The fast-moving melt-down of Wall Street powerhouse Weil, Gotshal & Manges stunned even legal insiders who were tracking its fortunes closely. But it's just the latest in a string of notable law firms ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...